Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Zhuoxin Zhou"'
Autor:
Kai Chen, Yingnan Si, Jia-Shiung Guan, Zhuoxin Zhou, Seulhee Kim, Taehyun Kim, Liang Shan, Christopher D. Willey, Lufang Zhou, Xiaoguang Liu
Publikováno v:
Biomedicines, Vol 12, Iss 1, p 86 (2023)
In the original publication [...]
Externí odkaz:
https://doaj.org/article/713513ee0b4e4563950e3f3c4a289f7c
Autor:
Jia-Shiung Guan, Kai Chen, Yingnan Si, Taehyun Kim, Zhuoxin Zhou, Seulhee Kim, Lufang Zhou, Xiaoguang Liu
Publikováno v:
Frontiers in Chemical Engineering, Vol 4 (2022)
Adeno-associated viruses (AAVs) have been well characterized and used to deliver therapeutic genes for diseases treatment in clinics and basic research. This study used the triple transient transfection of AAV-DJ/8 as a model expression system to dev
Externí odkaz:
https://doaj.org/article/a8ec81acc8cb4f5f9c8664762058d90b
Autor:
Kai Chen, Yingnan Si, Jia-Shiung Guan, Zhuoxin Zhou, Seulhee Kim, Taehyun Kim, Liang Shan, Christopher D. Willey, Lufang Zhou, Xiaoguang Liu
Publikováno v:
Biomedicines, Vol 10, Iss 1, p 130 (2022)
Glioblastomas, accounting for approximately 50% of gliomas, comprise the most aggressive, highly heterogeneous, and malignant brain tumors. The objective of this study was to develop and evaluate a new targeted therapy, i.e., highly potent natural co
Externí odkaz:
https://doaj.org/article/b31a9a1deba74cc6ad70fd268fdc00b8
Autor:
Yingnan Si, Kai Chen, Hanh Giai Ngo, Jia Shiung Guan, Angela Totoro, Zhuoxin Zhou, Seulhee Kim, Taehyun Kim, Lufang Zhou, Xiaoguang Liu
Publikováno v:
Pharmaceutics, Vol 14, Iss 1, p 146 (2022)
Triple-negative breast cancers (TNBCs) are heterogeneous and metastatic, and targeted therapy is highly needed for TNBC treatment. Recent studies showed that extracellular vesicles (EV) have great potential to deliver therapies to treat cancers. This
Externí odkaz:
https://doaj.org/article/44b01bbe71484da4bce774dcba57fe82
Autor:
Jia-Shiung Guan, Kai Chen, Yingnan Si, Taehyun Kim, Zhuoxin Zhou, Seulhee Kim, Lufang Zhou, Xiaoguang Liu
Publikováno v:
Front Chem Eng
Frontiers in Chemical Engineering, Vol 4 (2022)
Frontiers in Chemical Engineering, Vol 4 (2022)
Adeno-associated viruses (AAVs) have been well characterized and used to deliver therapeutic genes for diseases treatment in clinics and basic research. This study used the triple transient transfection of AAV-DJ/8 as a model expression system to dev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2985bcf10e0a81787ec9bbc155192c5a
https://pubmed.ncbi.nlm.nih.gov/35685827
https://pubmed.ncbi.nlm.nih.gov/35685827
Publikováno v:
Cancer Research. 82:5958-5958
Triple-negative breast cancers (TNBCs) are highly aggressive, heterologous and frequently recurrent. The standard radiotherapy and chemotherapy have limited clinical benefits while the combined therapies or antibody-drug conjugates (ADCs) are promisi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3092dfe0194447224d4ac973d517a985
https://doi.org/10.1158/1538-7445.am2022-5958
https://doi.org/10.1158/1538-7445.am2022-5958
Publikováno v:
Cancer Research. 82:5326-5326
Extracellular vesicles (EV), facilitated with cancer-targeted antibody or peptide, have been demonstrated as an effective delivery vehicle of chemotherapy and gene therapy. This study aimed to develop and evaluate a targeted EV to deliver a newly ide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00d3555bd188939b7ad0874b73cdb228
https://doi.org/10.1158/1538-7445.am2022-5326
https://doi.org/10.1158/1538-7445.am2022-5326
Autor:
Kai Chen, Yingnan Si, Jia-Shiung Guan, Zhuoxin Zhou, Seulhee Kim, Taehyun Kim, Liang Shan, Christopher D. Willey, Lufang Zhou, Xiaoguang Liu
Publikováno v:
Biomedicines
Biomedicines; Volume 10; Issue 1; Pages: 130
Biomedicines, Vol 10, Iss 130, p 130 (2022)
Biomedicines; Volume 10; Issue 1; Pages: 130
Biomedicines, Vol 10, Iss 130, p 130 (2022)
Glioblastomas, accounting for approximately 50% of gliomas, comprise the most aggressive, highly heterogeneous, and malignant brain tumors. The objective of this study was to develop and evaluate a new targeted therapy, i.e., highly potent natural co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f57569fcc878b2372a494763e37582e8
https://pubmed.ncbi.nlm.nih.gov/35052809
https://pubmed.ncbi.nlm.nih.gov/35052809
Autor:
Chen, Kai, Si, Yingnan, Guan, Jia-Shiung, Zhou, Zhuoxin, Kim, Seulhee, Kim, Taehyun, Shan, Liang, Willey, Christopher D., Zhou, Lufang, Liu, Xiaoguang
Publikováno v:
Biomedicines; Jan2024, Vol. 12 Issue 1, p86, 2p
Autor:
Zhang, Jiashuai1 (AUTHOR) zhang.13284@osu.edu, Zhou, Zhuoxin2 (AUTHOR) zhou.4213@osu.edu, Chen, Kai2 (AUTHOR) chen.12100@osu.edu, Kim, Seulhee1 (AUTHOR) kim.8819@osu.edu, Cho, Irene Soohyun2 (AUTHOR) cho.766@osu.edu, Varadkar, Tanvi2 (AUTHOR) varadkar.1@osu.edu, Baker, Hailey1 (AUTHOR) baker.2718@osu.edu, Cho, Ju Hwan3 (AUTHOR) cho.622@osu.edu, Zhou, Lufang1,3 (AUTHOR) zhou.4212@osu.edu, Liu, Xiaoguang2,3 (AUTHOR) liu.482@osu.edu
Publikováno v:
Cells (2073-4409). Oct2023, Vol. 12 Issue 19, p2393. 14p.